Core Viewpoint - Meili Tianyuan Healthcare (02373) has repurchased shares, indicating management's confidence in the company's long-term value and business prospects [1] Summary by Sections Share Repurchase Details - The company repurchased 80,000 shares on November 28, 2025, for approximately HKD 2.0074 million, at an average price of HKD 25.09 per share [1] - From October 15, 2025, to the date of the announcement, the total shares repurchased amounted to 695,000, with a total cost of approximately HKD 20.6924 million [1] Management's Perspective - The board believes that the current share price does not reflect the intrinsic value of the shares and the actual business outlook of the company [1] - The share repurchase is seen as a demonstration of management's strong confidence in the company's long-term value, which is expected to enhance the group's market value and shareholder return capabilities [1] - The board asserts that the repurchase aligns with the overall interests of the company and its shareholders [1]
美丽田园医疗健康11月28日斥资约200.74万港元购回8万股